Apurva C.

WORK HISTORY

ABOUT APURVA C.

Extensive pharmacology, toxicology, disease biology, and relevant regulatory experience working across multiple therapeutics areas (Metabolic diseases, Inflammatory bowel disease, Liver disease, Neurodegenerative diseases, and oncology) for fusion protein, antibody, and small molecule drugs. Successfully and directly propels projects towards clinical trials. Contributed pre-clinical efforts to clinical trial products for TB006 (Alzheimer\'s, Acute Ischemic Stroke and COVID), AMT-101 (Oral IL-10, Ulcerative Colitis), AMT-126 (Oral IL-22, GI Barrier repair), MBX-2982 (GPR119, Type 2 Diabetes), MBX-102 (Selective PPARg Modulator), Seladelpar (MBX-8025 PPARδ agonist), A-005 (Multiple Sclerosis), ESK-001 (LUPUS and Psoriasis late stage) Directly contributes to multiple stages drug discovery and development from preclinical to clinical and beyond. Supported clinical development: Regulatory documents (Protocol, IB etc), and bioanalytical development/management. Partner with cross-functional leaders to develop comprehensive product development (Non-Clinical, Clinical, CMC, Regulatory) that optimize: value, time, resources, risk, and alignment with business objectives Specialties: Preclinical and clinical development, Translational medicine, Biomarker development, Bioanalytical development, Laboratory start-up and operations Liaise business and scientific activities, Staff management and team leadership Responsible for coordination of scientific projects from initiation to completion, writing reports, managing deadlines and resources, communicating goals, and monitoring progress. Highly motivated, efficient, result oriented, flexible and productive professional with strong analytical, problem-solving, prioritization and multitasking abilities. Manage and provide leadership/mentorship to a team of high performing scientist. Best career advice received: You are a scientist and a people person…so help people work together to do the best science.